Drug Pipeline

KYV-101 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
1
Phase 3
2
Top Sponsors
Active Studies by Phase
Phase 2/3
1
Phase 1
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT06193889 KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With… Myasthenia Gravis Recruiting
Phase 1
NCT06152172 CARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101 Idiopathic Inflammatory Myopathies Active, Not Recruiting
Not specified
NCT07403188 A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101 Refractory Lupus Nephritis Recruiting
Sponsors Running KYV-101 Trials
Kyverna Therapeutics (2) David Porter (1)
Disease Areas
Lupus (SLE) (2) Scleroderma (2) Myasthenia Gravis (1) Multiple Sclerosis (1) Rheumatoid Arthritis (1)
Get alerts when KYV-101 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free